146 related articles for article (PubMed ID: 15456853)
1. Visualization of SHP-1-target interaction.
Biskup C; Böhmer A; Pusch R; Kelbauskas L; Gorshokov A; Majoul I; Lindenau J; Benndorf K; Böhmer FD
J Cell Sci; 2004 Oct; 117(Pt 21):5165-78. PubMed ID: 15456853
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1.
Keilhack H; Müller M; Böhmer SA; Frank C; Weidner KM; Birchmeier W; Ligensa T; Berndt A; Kosmehl H; Günther B; Müller T; Birchmeier C; Böhmer FD
J Cell Biol; 2001 Jan; 152(2):325-34. PubMed ID: 11266449
[TBL] [Abstract][Full Text] [Related]
3. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
[TBL] [Abstract][Full Text] [Related]
4. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
[TBL] [Abstract][Full Text] [Related]
5. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
8. The Shp-1 and Shp-2, tyrosine phosphatases, are recruited on cell membrane in two distinct molecular complexes including Ret oncogenes.
Incoronato M; D'Alessio A; Paladino S; Zurzolo C; Carlomagno MS; Cerchia L; de Franciscis V
Cell Signal; 2004 Jul; 16(7):847-56. PubMed ID: 15115663
[TBL] [Abstract][Full Text] [Related]
9. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
13. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of FRS2 in insulin signaling.
Delahaye L; Rocchi S; Van Obberghen E
Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
[TBL] [Abstract][Full Text] [Related]
15. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.
Feng YH; Sun Y; Douglas JG
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12049-54. PubMed ID: 12221292
[TBL] [Abstract][Full Text] [Related]
16. Opposite regulation of tyrosine-phosphorylation of p130(Cas) by insulin and insulin-like growth factor I.
Fujita T; Maegawa H; Kashiwagi A; Hirai H; Kikkawa R
J Biochem; 1998 Dec; 124(6):1111-6. PubMed ID: 9832615
[TBL] [Abstract][Full Text] [Related]
17. Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera.
Tenev T; Keilhack H; Tomic S; Stoyanov B; Stein-Gerlach M; Lammers R; Krivtsov AV; Ullrich A; Böhmer FD
J Biol Chem; 1997 Feb; 272(9):5966-73. PubMed ID: 9038217
[TBL] [Abstract][Full Text] [Related]
18. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.
Kozlowski M; Larose L; Lee F; Le DM; Rottapel R; Siminovitch KA
Mol Cell Biol; 1998 Apr; 18(4):2089-99. PubMed ID: 9528781
[TBL] [Abstract][Full Text] [Related]
19. Effective dephosphorylation of Src substrates by SHP-1.
Frank C; Burkhardt C; Imhof D; Ringel J; Zschörnig O; Wieligmann K; Zacharias M; Böhmer FD
J Biol Chem; 2004 Mar; 279(12):11375-83. PubMed ID: 14699166
[TBL] [Abstract][Full Text] [Related]
20. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
